Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 14:23:07 UTC
Update Date2021-09-26 23:09:19 UTC
HMDB IDHMDB0254904
Secondary Accession NumbersNone
Metabolite Identification
Common NameMotolimod
DescriptionMotolimod belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). Motolimod is a very strong basic compound (based on its pKa). In June 2018, the combination of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) was approved by the Food and Drug Administration for the treatment of people with unresectable or metastatic BRAF V600E or V600K mutation-positive melanoma. In 2017, the company spun out one of its programs into a subsidiary called Yarra; the asset was a molecule called ARRY-797 that was in a Phase II trial for cardiomyopathy. In May 2017, the company partnered with Ono Pharmaceutical to test the combination of binimetinib and encorafenib while retaining commercialization rights in the U.S. and other markets. In July 2019, Pfizer acquired the company. In November 2015, the company signed a partnership with Laboratoires Pierre Fabre. The company focuses on oncology medication. Array BioPharma is a U.S.-based, clinical stage, pharmaceutical company. In July 2013, the company partnered with Loxo Oncology to develop cancer drugs. This compound has been identified in human blood as reported by (PMID: 31557052 ). Motolimod is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Motolimod is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
VTX-378VTX-2337MOTOLIMODChEMBL
Chemical FormulaC28H34N4O2
Average Molecular Weight458.606
Monoisotopic Molecular Weight458.268176351
IUPAC Name2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide
Traditional Name2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide
CAS Registry NumberNot Available
SMILES
CCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC1
InChI Identifier
InChI=1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30)
InChI KeyQSPOQCXMGPDIHI-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom).
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzazepines
Sub ClassNot Available
Direct ParentBenzazepines
Alternative Parents
Substituents
  • Benzazepine
  • Benzamide
  • Benzoic acid or derivatives
  • Benzoyl
  • N-acylpyrrolidine
  • Azepine
  • Monocyclic benzene moiety
  • Imidolactam
  • Benzenoid
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Carboxamide group
  • Amidine
  • Azacycle
  • Carboxylic acid amidine
  • Organic 1,3-dipolar compound
  • Carboxylic acid derivative
  • Propargyl-type 1,3-dipolar organic compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.67ALOGPS
logP3.74ChemAxon
logS-5ALOGPS
pKa (Strongest Basic)7.93ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area79 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity140.03 m³·mol⁻¹ChemAxon
Polarizability54.06 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+219.73430932474
DeepCCS[M-H]-217.33830932474
DeepCCS[M-2H]-250.22130932474
DeepCCS[M+Na]+225.64630932474
AllCCS[M+H]+213.632859911
AllCCS[M+H-H2O]+211.532859911
AllCCS[M+NH4]+215.532859911
AllCCS[M+Na]+216.132859911
AllCCS[M-H]-209.632859911
AllCCS[M+Na-2H]-211.332859911
AllCCS[M+HCOO]-213.332859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MotolimodCCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC15348.8Standard polar33892256
MotolimodCCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC14365.7Standard non polar33892256
MotolimodCCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC14486.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Motolimod,1TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C14295.4Semi standard non polar33892256
Motolimod,1TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C13865.8Standard non polar33892256
Motolimod,1TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C15902.2Standard polar33892256
Motolimod,2TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C14334.1Semi standard non polar33892256
Motolimod,2TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C13985.6Standard non polar33892256
Motolimod,2TMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C15647.5Standard polar33892256
Motolimod,1TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C14518.7Semi standard non polar33892256
Motolimod,1TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C14073.3Standard non polar33892256
Motolimod,1TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C15853.6Standard polar33892256
Motolimod,2TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C14689.7Semi standard non polar33892256
Motolimod,2TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C14384.3Standard non polar33892256
Motolimod,2TBDMS,isomer #1CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C15581.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Motolimod GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4r-3009300000-61d176283c6bb192a7bd2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Motolimod GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 10V, Positive-QTOFsplash10-0a4i-2103900000-96e519c0f62aa7e1d6af2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 20V, Positive-QTOFsplash10-0536-4119400000-185e29e9ad83af1e38e92017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 40V, Positive-QTOFsplash10-0006-9060000000-38b8ce6b0bf61ff65a1b2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 10V, Negative-QTOFsplash10-0a4i-0000900000-115bd3957f84fd7a694a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 20V, Negative-QTOFsplash10-0a4j-5403900000-ab185407c25bf177ee1e2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 40V, Negative-QTOFsplash10-0006-9001000000-1f12a104754b39bd08682017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 10V, Positive-QTOFsplash10-0a4i-0001900000-42b59379cf8899f1475d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 20V, Positive-QTOFsplash10-0a4i-8009700000-5c4cf7cbaf88fa75d85c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 40V, Positive-QTOFsplash10-0006-9015400000-7883eddcffe3c39ceade2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 10V, Negative-QTOFsplash10-0a4i-0000900000-3730f7726aac8ae4ca8e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 20V, Negative-QTOFsplash10-0a4i-1103900000-921d0b065b69f91e1f8a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Motolimod 40V, Negative-QTOFsplash10-053r-4019300000-295124a047502e5cd1e62021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB12303
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkArray BioPharma
METLIN IDNot Available
PubChem Compound16049404
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]